EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm

Letícia Rampazzo da Gama Viveiro iD, Amanda Rodrigues Rehem, Evelyn Luzia De Souza Santos, Paulo Henrique Fonseca do Carmo, Juliana Campos Junqueira iD, Liliana Scorzoni

Pathogens and Disease · 2024

DOI: 10.1093/femspd/ftae001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Disease, 2024. Verfasst von Letícia Rampazzo da Gama Viveiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São Paulo 12245-000, Brazil. Hauptthemen laut MEDLINE: Cryptococcus gattii, Cryptococcus neoformans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by Cryptococcus gattii mainly affect immunocompetent individuals and the treatment presents important limitations. This study aimed to validate the efficacy of selective serotonin reuptake inhibitors (SSRI), fluoxetine hydrochloride (FLH), and paroxetine hydrochloride (PAH) in vitro against C. gattii. The antifungal activity of SSRI using the microdilution method revealed a minimal inhibitory concentration (MIC) of 31.25 µg/ml. The combination of FLH or PAH with amphotericin B (AmB) was analyzed using the checkerboard assay and the synergistic effect of SSRI in combination with AmB was able to reduce the SSRI or AmB MIC values 4–8-fold. When examining the effect of SSRI on the induced capsules, we observed that FLH and PAH significantly decreased the size of C. gattii capsules. In addition, the effects of FLH and PAH were evaluated in biofilm biomass and viability. The SSRI were able to reduce biofilm biomass and biofilm viability. In conclusion, our results indicate the use of FLH and PAH exhibited in vitro anticryptococcal activity, representing a possible future alternative for the cryptococcosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptococcus gattiiCryptococcus neoformansHumansSelective Serotonin Reuptake InhibitorsAntifungal AgentsAmphotericin BMicrobial Sensitivity TestsFluoxetineParoxetineBiofilms

Stichwörter der Autor:innen

Cryptococcus gattiiAntifungalBiofilmSerotonin reuptake inhibitors

Substanzen

Selective Serotonin Reuptake InhibitorsAntifungal AgentsAmphotericin BFluoxetineParoxetine

Autor:innen und Institutionen

  • Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São Paulo 12245-000, Brazil.
  • Programa de Pós-Graduação em Enfermagem, Universidade de Guarulhos, Guarulhos, São Paulo 07023-070, Brazil.

ORCID-Profile: Letícia Rampazzo da Gama Viveiro, Juliana Campos Junqueira

Zitieren

APA

Viveiro, L. R. D. G., Rehem, A. R., Santos, E. L. S., Carmo, P. H. F. D., Junqueira, J. C., & Scorzoni, L. (2024). In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm. Pathogens and Disease. https://doi.org/10.1093/femspd/ftae001

Vancouver

Viveiro LRDG, Rehem AR, Santos ELS, Carmo PHFD, Junqueira JC, Scorzoni L. In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm. Pathogens and Disease. 2024. doi:10.1093/femspd/ftae001

BibTeX
@article{Viveiro2024,
  author = {Viveiro, Letícia Rampazzo da Gama and Rehem, Amanda Rodrigues and Santos, Evelyn Luzia De Souza and Carmo, Paulo Henrique Fonseca do and Junqueira, Juliana Campos and Scorzoni, Liliana},
  title = {In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm},
  journal = {Pathogens and Disease},
  year = {2024},
  doi = {10.1093/femspd/ftae001}
}
Kostenlos starten →